作为多发性骨髓瘤脆弱患者更有效的治疗方法,更强烈的治疗方法 [纠正]
Clark DuMontier1,2,3,4, Jennifer La4,5, John Bihn5
1New England Geriatrics Research, Education and Clinical Center, VA Boston Healthcare System, Boston, MA.
Blood advances
|August 15, 2023
概括
更强烈的博特佐米布-莱纳利多米德-脱沙美 (VRd) 治疗改善了新诊断的多发性骨髓瘤 (MM) 患者的生存率,包括那些有显著脆弱的患者. 这表明密集的MM疗法也可以治疗虚弱本身.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
背景情况:
- 随机对照试验表明,博尔特佐米布-莱纳利多米德-甲 (VRd) 对新诊断的多发性骨髓瘤 (MM) 优于莱纳利多米德-甲 (Rd).
- 临床指导方针历来倾向于Rd用于不能容忍三重治疗的脆弱患者.
- 脆弱性评估对于老年MM患者的治疗决策至关重要.
研究的目的:
- 为了比较VRd与Rd在美国退伍军人事务卫生保健系统中新诊断的MM患者的真实环境中的有效性.
- 研究通过退伍军人事务脆弱指数衡量的脆弱性对接受VRd或Rd的MM患者治疗结果的影响.
- 为了确定VRd对Rd的好处是否延伸到脆弱的患者群体.
主要方法:
- 对2573名新诊断的MM患者 (2004-2020年) 的回顾性分析,该分析始于VRd或Rd.
- 倾向性得分匹配用于根据MM阶段和其他混因素平衡患者组.
- 退伍军人事务脆弱性指数被用来将患者分为非脆弱,轻微脆弱和中度至严重脆弱的群体.
主要成果:
- 在总体匹配的MM人群中,VRd与Rd相比死亡率显著降低 (HR,0.81).
- 在中度至重度虚弱的患者中,VRd的生存益处最为明显 (HR,0.74),在轻度虚弱和非虚弱的群体中效果减弱.
- 虽然VRd与整体住院病例的适度增加有关,但这种关联在中度至重度虚弱患者中减弱.
结论:
- 研究结果证实,在美国老年MM患者中,VRd与Rd相比,VRd的生存结果优越.
- 强化VRd疗法在患有较高脆弱度的患者中显示出最大的益处.
- 多发性骨髓瘤的密集治疗策略可能通过解决脆弱性本身来提供双重好处.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Chronic Kidney Disease IV: Nursing Management
25
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
25


